Thiethylperazine malate

苹果酸硫乙拉嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameThiethylperazine malate
Drug Alias NameMalato de tietilperazina苹果酸甲哌硫丙嗪Thiethylperazini Malas苹果酸硫乙哌丙嗪Torecan
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D4 receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D1 receptorDopamine D2 receptorDopamine D4 receptor
Therapy Area/IndicationsVomitingNausea
Global Approved IndicationsVomitingNausea
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/07/18
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsVomitingNausea

Other Information

ATC CodeR06AD03
Related LinksWikipediaDrugBankKEGG